45 related articles for article (PubMed ID: 38622605)
1. Guanylate-Binding Protein 1: An Emerging Target in Inflammation and Cancer.
Honkala AT; Tailor D; Malhotra SV
Front Immunol; 2019; 10():3139. PubMed ID: 32117203
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
3. Interferon-γ-induced GBP1 is an inhibitor of human papillomavirus 18.
Xu M; Lin MC; Li ZH
BMC Womens Health; 2024 Apr; 24(1):240. PubMed ID: 38622605
[TBL] [Abstract][Full Text] [Related]
4. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
5. Messenger ribonucleic acid encoding interferon-inducible guanylate binding protein 1 is induced in human endometrium within the putative window of implantation.
Kumar S; Li Q; Dua A; Ying YK; Bagchi MK; Bagchi IC
J Clin Endocrinol Metab; 2001 Jun; 86(6):2420-7. PubMed ID: 11397834
[TBL] [Abstract][Full Text] [Related]
6. High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression.
Poirson J; Suarez IP; Straub ML; Cousido-Siah A; Peixoto P; Hervouet E; Foster A; Mitschler A; Mukobo N; Chebaro Y; Garcin D; Recberlik S; Gaiddon C; Altschuh D; Nominé Y; Podjarny A; Trave G; Masson M
J Virol; 2022 May; 96(10):e0187521. PubMed ID: 35475668
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immune responses to human papillomavirus 16 E6 and E7 antigens as measured by interferon gamma enzyme-linked immunospot in women with cleared or persistent human papillomavirus infection.
Farhat S; Nakagawa M; Moscicki AB
Int J Gynecol Cancer; 2009 May; 19(4):508-12. PubMed ID: 19509544
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma produced by human papilloma virus-18 E6-specific CD4+ T cells predicts the clinical outcome after surgery in patients with high-grade cervical lesions.
Seresini S; Origoni M; Lillo F; Caputo L; Paganoni AM; Vantini S; Longhi R; Taccagni G; Ferrari A; Doglioni C; Secchi P; Protti MP
J Immunol; 2007 Nov; 179(10):7176-83. PubMed ID: 17982110
[TBL] [Abstract][Full Text] [Related]
9. HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase TOP2A expression.
Zhang J; Yu X; Guo Y; Wang D
Cancer Med; 2024 Feb; 13(3):e6875. PubMed ID: 38205938
[TBL] [Abstract][Full Text] [Related]
10. HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor.
Peng Q; Wang L; Zuo L; Gao S; Jiang X; Han Y; Lin J; Peng M; Wu N; Tang Y; Tian H; Zhou Y; Liao Q
Cancer Gene Ther; 2024 Jan; 31(1):9-17. PubMed ID: 38102462
[TBL] [Abstract][Full Text] [Related]
11. Activating STING/TBK1 suppresses tumor growth via degrading HPV16/18 E7 oncoproteins in cervical cancer.
Huang X; Huo L; Xiao B; Ouyang Y; Chen F; Li J; Zheng X; Wei D; Wu Y; Zhang R; Cao X; Kang T; Gao Y
Cell Death Differ; 2024 Jan; 31(1):78-89. PubMed ID: 38007552
[TBL] [Abstract][Full Text] [Related]
12. Malignancy Associated with Low-Risk HPV6 and HPV11: A Systematic Review and Implications for Cancer Prevention.
Silva LLD; Teles AM; Santos JMO; Souza de Andrade M; Medeiros R; Faustino-Rocha AI; Oliveira PA; Dos Santos APA; Ferreira Lopes F; Braz G; Brito HO; Costa RMGD
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627099
[TBL] [Abstract][Full Text] [Related]
13. Cervical Cancer Screening: A Review.
Perkins RB; Wentzensen N; Guido RS; Schiffman M
JAMA; 2023 Aug; 330(6):547-558. PubMed ID: 37552298
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus E5 suppresses immunity via inhibition of the immunoproteasome and STING pathway.
Miyauchi S; Kim SS; Jones RN; Zhang L; Guram K; Sharma S; Schoenberger SP; Cohen EEW; Califano JA; Sharabi AB
Cell Rep; 2023 May; 42(5):112508. PubMed ID: 37171962
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus vaccination and cervical cancer risk.
Rahangdale L; Mungo C; O'Connor S; Chibwesha CJ; Brewer NT
BMJ; 2022 Dec; 379():e070115. PubMed ID: 36521855
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]